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in Inpatient Treatment of
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ABSTRACT
Post-traumatic stress disorder (PTSD) is the most widespread mental illness
resulting from exposure to combat, necessitating an increase in the provision of
group therapy. This pilot study examined the efficacy of, and treatment outcome
predictors associated with, group inpatient treatment of combat-related PTSD.
Participants included 38 active duty military personnel deployed during Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF), diagnosed with PTSD, and consecutive admissions to an inpatient PTSD treatment
facility. A paired samples t-test revealed significant change in symptom severity
and global functioning between pre- and post-treatment. Multiple regression
analyses supported the predictive utility of baseline symptomatology and group
cohesion (> 50% of the variance in treatment outcome), highlighting the importance of group cohesion in the efficacy of group treatment for combat-related
PTSD.
Carilyn C. Ellis, Mary Peterson, and Rodger Bufford are affiliated with the Graduate
Department of Clinical Psychology at George Fox University in Newberg, Oregon. Jon
Benson, a graduate of George Fox University’s Clinical Psychology Program, provides
contract supervision for doctoral students at the inpatient hospital that was the focus of
study for this research.
This research was funded by a Richter Scholar Grant awarded to Carilyn C. Ellis by
George Fox University. Special acknowledgements are offered to Lynn McDowell, LPC,
and Timothy Cooper, M.A., for their assistance in conducting this research.

A

ccording to the United States Department of Veterans Affairs
(VA) and the United States Department of Defense (DoD; U.S.
Department of Veterans Affairs [VA/DoD], 2004), post-traumatic stress disorder (PTSD) is the most common and widespread
mental illness resulting from exposure to combat. PTSD impacts
multiple domains of psychological and interpersonal functioning. According to Kessler (2000), people with PTSD are 1.5 times
more likely to be unemployed than people without PTSD, and
their chances of marital discord are increased by 60%. According
to Gavlovski and Lyons (2003), the risk of suicide associated with
PTSD exceeds that of any other anxiety disorder. Most of the research into PTSD, especially combat-related PTSD, suggests that
it is a chronic and debilitating disorder that is difficult to treat. A
large-scale follow-up of combat veterans two years after receiving
treatment for PTSD found that two-thirds of the population surveyed had small to no improvement in symptoms (Creamer, Elliott, Forbes, Biddle, & Hawthorne, 2006). Continued research is
necessary to improve treatment outcomes and better understand
combat-related PTSD.
According to Riddle and colleagues (2007), PTSD is currently
the second most common clinical diagnosis in the military, affecting 2.4% of the current millennium cohort. The U.S. Department
of Veterans Affairs National Center for PTSD (2010) estimates
between 6 and 11% of veterans from the conflicts in Afghanistan
and 12% to 20% of veterans from the conflicts in Iraq have PTSD.
Forbes and colleagues (2008) proposed, “optimizing treatment
effectiveness through understanding factors that influence treatment outcome, and tailoring interventions to presentation type,
is critical” in working with combat-related PTSD (p. 142).
The VA currently provides two forms of evidence-based treatments for PTSD, cognitive processing therapy (CPT; Resick,
Monson, & Chard, 2008) and prolonged exposure therapy (PE;
Hamblen, 2010). According to Freedberg (2008), the two techniques have significant overlap, with CPT attempting to change
the thought perceptions related to the traumatic experience and
PE attempting to change the emotions related to the traumatic
experience. Both have been shown to be effective in individual
settings. With the exception of a few studies validating the origi-

nal feasibility and efficacy of CPT in group treatment settings,
both models remain relatively untested in the context of group
treatment, especially in the context of inpatient, group treatment
of combat-related PTSD.
The VA-approved therapeutic interventions of CPT and PE are
found to be effective in an individual therapy setting. However,
the growing needs of the combat veteran community and the
continuing conflicts in the Middle East will necessitate the use of
group treatment for PTSD (Kingsley, 2007) due to the volume of
service members needing treatment. There appears to be minimal discussion in the literature about the facilitation of inpatient
group treatment of combat veterans and active duty military and
respective treatment outcomes. Group treatment is absent from
the VA/DoD Clinical Practice Guideline for the Management of PostTraumatic Stress (VA/DoD, 2004). Given the increasing need for
group treatment of combat veterans, the study of interventions
and treatment outcomes in group settings is necessary for enhancing group treatment of combat-related PTSD. Group modules do exist for CPT; however, they require some editing of the
construct in order to be administered in a group setting. One
of the principal elements of the 12-step process of CPT is the
trauma statement, in which a combat veteran is asked to describe
in detail his or her experience that led to PTSD. According to
nationally certified VA trainer, Amy Williams, Ph.D., it is recommended that this aspect of CPT be omitted from group settings
to reduce the effect of vicarious trauma—that is, providing additional stress or triggering veterans who may have not had the
same experience. As a result, use of CPT in a group setting tends
to focus more on the impact of trauma (the ecological results of
the traumatic experiences, such as not being able to trust others, relationship conflict, etc.), rather than the specific traumatic
experiences, which are given more focus in individual treatment.
The purpose of this study was (1) to examine the efficacy of
CPT as a method of treating combat-related PTSD in a group,
inpatient setting, and (2) to evaluate whether patient-specific
predictor variables that have been known to impact individual
treatment continue to impact treatment in a group setting, and
if group cohesion serves as an additional predictor variable in
the group inpatient treatment of combat-related PTSD. This pilot

study offers a preliminary examination of these goals in a single,
uncontrolled sample of active duty military participants receiving treatment in an inpatient setting.
To date, several studies have examined variables influencing
treatment outcome in PTSD, such as baseline PTSD symptomatology (Karatzias et al., 2007), anger (Forbes et al., 2008), and
personality factors (Forbes et al., 2002), among others. The effects of each of these factors have been measured in the context
of individual therapy. However, few studies have examined the
complex interplay of these factors and their effect on outcomes
of group, inpatient treatment of combat-related PTSD.
In their study, Karatzias and colleagues (2007) found that baseline PTSD symptomatology as assessed by the PTSD Symptom
Checklist (PCL) was a significant treatment outcome predictor
regardless of whether symptoms were assessed by a clinician
(CAPS) or self-reported by patients using the Impact of Events
Scale (IES) and the PCL. King and colleagues (2006) found that
assessing the severity of combat itself (specific traumatic experiences that occurred during combat), which is the primary focus of instruments like the PCL and CAPS, is not encompassing
enough for addressing combat-related PTSD. Research by the National Center for PTSD has found that stronger associations exist
between post-combat experiences (e.g., body retrieval, providing
medical attention to wounded comrades) and symptom severity
in PTSD than with the actual severity of combat itself (King et
al., 2006). However, the latter is the focus of most symptom measures. Therefore, it is important to measure the comprehensive
experiences of deployment in addition to direct combat trauma
in the assessment of baseline symptomatology in PTSD.
Personality factors associated with PTSD outcomes tend to
concentrate more in the avoidance and arousal symptom clusters
of PTSD. In their study of the impact of personality factors and
mechanisms of anger on the outcome of PTSD treatment, Forbes
and colleagues (2002) and Forbes and colleagues (2008) found
that personality factors associated with social alienation and anger at intake were predictive of change in PCL scores. The effects
of anger are often comorbid with factors like alcohol use and
amount of concern the veteran has about his or her experience of
anger and its consequences, suggesting that anger may be an in-

dex factor for the amount of control a combat veteran feels over
the environment and experience of symptoms. As a result, veterans diagnosed with PTSD with personality factors associated with
aggression and anger may fear losing control, and subsequently
isolate themselves, in an effort to manage their symptoms. Personality factors associated specifically with social isolation, such
as social detachment and social phobia, as measured by the Personality Assessment Inventory (PAI; Morey, 1991) also correlate
with changes in symptom severity.
According to research by Crowe and Grenyer (2008), subjective
experiences of recovery reported by patients in group treatment
settings appear to be associated more with the social functions
of group therapy (e.g., being around others with similar experiences, enhancing empathy, camaraderie), rather than individual
therapist or modalities of treatment. Group treatment provides
an opportunity to reduce the emotional isolation experienced by
combat veterans by fostering a sense of cohesion between common cohort members, as evidenced by the report of veterans
surveyed by Freedberg (2008). This suggests that in addition to
the aforementioned patient-specific factors, group cohesion may
prove to be a valuable aspect of assessment and important therapeutic goal
METHODS
Participants

Participants consisted of a census of consecutive admissions to an
inpatient program for the treatment of PTSD in combat veterans.
Participants included 37 male and 1 female active duty military
personnel who were veterans of Operation Enduring Freedom
(OEF) and Operation Iraqi Freedom (OIF). PTSD diagnoses
were confirmed by medical records, self-report symptom score
at admission, and psychiatric verification of diagnosis. Criteria
for inclusion in the study were the presence of combat exposure
during the OEF and/or OIF conflicts combined with a PTSD diagnosis. All participants completed a minimum 28-day treatment
protocol, including two to four hours of daily group therapy using a CPT model (Resick et al., 2008), a 12-step program for co-

occurring substance abuse/dependence (as appropriate), and
additional milieu treatment. Therapists were licensed in the state
and certified in training for CPT from a nationally accredited VA
trainer. Demographic information obtained included age, military branch, number of deployments, duration of deployments,
marital status, number of children, custody arrangement, ethnicity, and presence of chemical dependency.
Measures

A variety of self-report measures were used to assess effectiveness
of treatment, baseline symptomatology, symptom improvement,
and additional treatment predictor variables. These measures,
listed below, assessed severity of combat exposure, global personality factors, PTSD symptoms, social/interpersonal well-being,
and aspects of group cohesion:
Treatment Effectiveness

Treatment effectiveness was operationally defined as a clinically
significant reduction in the severity of PTSD, as measured by the
PTSD Checklist – Military Version (PCL-M; Weathers, Keane, &
Davidson, 2001), and/or a statistically significant improvement
in quality of life as measured by the Outcome Rating Scale (ORS;
Duncan et al., 2003).
PCL-M. The PCL-M is a 17-item self-report measure of the
Diagnostic and Statistical Manual of Mental Disorders, 4th edition
(DSM-IV-TR; American Psychiatric Association, 2000), symptoms
of PTSD for military personnel. The PCL has a high internal consistency (α = .91–.96), and strong convergent validity (r = 0.79)
with the CAPS (Keen, Kutter, Niles, & Krinsley, 2008). Clinical
applications of the PCL-M have used cutoff scores ranging from
50–60 as the baseline to establish clinical significance in a PTSD
diagnosis (Keen et al., 2008). The clinical cutoff for this study was
set as an average of the range, at 55.
ORS. The ORS is a 4-item visual analogue self-report outcome
measure designed for tracking client progress in four interpersonal domains. Normative data for global functioning in a clinical population using the ORS suggest an overall mean of 19.6
(SD = 8.7) for the four subscales (Duncan et al., 2003), with a

corresponding average of 4.9 (out of a 10-point Likert-type scale).
The overall alpha for internal consistency on ORS administration
is high (α = .97). Some studies have indicated that the test-retest
reliability for the ORS is moderately high (r = .80 and .81, respectively for one- to three-week retests; Bringhurst, Watson, Miller, &
Duncan, 2006). The correlation between the Outcome Questionnaire 45.2 (OQ-45.2; Lambert et al., 1996) and the ORS is .59,
indicating a moderate, but acceptable level of concurrent validity (Bringhurst et al., 2006). The ORS demonstrated construct
validity by showing significantly different scores between treatment and non-treatment populations (Miller, Duncan, Brown,
Sparks, & Claud, 2003). In addition to demonstrating differences
between clinical and non-clinical samples, construct validity was
also shown by the differences in pre-treatment and post-treatment patient scores (Miller et al., 2003). Based on a sample of
35,000 patients and a clinical cut-off score of 25, Duncan and
colleagues (2003) calculated a reliable change index (RCI), which
and showed that a difference of 5 points between pre- and postscores demonstrated a clinically significant change.
Predictor Variables

Baseline symptomatology was assessed using the PCL-M, ORS,
and Deployment Risk and Resilience Inventory (DRRI; U.S. Department of Veterans Affairs National Center for PTSD [VA/
National Center], 2011) in an effort to identify comprehensive
deployment variables that impact baseline symptom severity.
DRRI. The DRRI is a 203-item deployment experience selfreport measure comprised of yes/no and 5-point Likert-style
questions designed by the National Centers for PTSD, as part
of the VA, for research and descriptive purposes about personal
history and deployment experiences. It contains 13 scales, ranging from A: Pre-Deployment Life Events through encompassing
combat and comprehensive deployment experiences to M: PostDeployment Life Events. Early psychometric assessment of the
DRRI is encouraging, suggesting that it has promise for reliably
assessing risk and resilience factors that contribute to veterans’
pre- and post-deployment well-being (King et al., 2006). The developmental foundations of the measure, specifically its factor

analysis, allow for each of the measures in the DRRI to be used
as a stand-alone instrument. No clinical cut-off scores exist for
classifying clients into diagnostic groups, and clinical norms have
not been yet established (VA/National Center, 2011).
PAI. Personality variables specific to aggression, anger, and social isolation were measured using the Personality Assessment
Inventory (PAI; Morey, 1991), a 344-item self-report inventory
that assesses various domains of personality and psychopathology among adults. It was designed for use in professional and
research settings. The PAI has a moderately high test-retest reliability on the clinical scales (r = .79-.92; Morey, 1991).
CALPAS-G. Group cohesion was measured using the California Psychotherapy Alliance Scale – Group Version (CALPAS-G;
Gaston & Marmar, 1994). The CALPAS-G is a 12-item scale measuring group cohesion in treatment through four subscales. The
Patient Working Capacity Scale (PWC) assesses the patient’s willingness to engage in group therapy as a result of the group’s dynamics. Patients rate their working capacity for each question on
a Likert-style scale ranging from “0 – not at all” to “6 – very much
so.” Gaston and Marmar (1993) define the PWC scale as “the
group members’ ability or preparedness to self disclosure and
self-reflect on salient therapy themes; to explore their contribution to problems; to experience strong emotions in a modulated
fashion; to actively use therapist’s comments; to deepen exploration of salient themes; and to purposefully work towards solving
problems” (p. 5). The Patient Commitment Scale (PC) assesses
the patient’s commitment to attending group and following
through with group practice, the Working Strategy Consensus
(WSC) scale assesses the patient’s sense of alignment with other
group members and their common goals, and the Member Understanding and Involvement Scale (MUI) assesses the patient’s
sense that other group members understand his or her specific
experiences (Gaston & Marmar, 1994). The CALPAS-G has been
shown to effectively assess group cohesion in previous studies
(Crowe & Grenyer, 2008).

Procedure

Each participant was administered a battery of self-report measures upon admission to establish a baseline patient profile. This
battery consisted of the DRRI, PAI, PCL-M, and ORS. During
their inpatient stay, patients participated in a minimum of two
hours of PTSD group therapy per day, as well as additional individual therapy sessions with a unit therapist, milieu treatment,
and group therapy addressing substance abuse if comorbid diagnosis was present. Upon termination of treatment, a PCL-M,
ORS, and the CALPAS-G were administered. All measures were
self-report, paper administered, and completed by the patients.
Data Analysis

The data were analyzed using SPSS Version 18.0. A paired samples t-test was performed comparing the means of baseline symptomatology (PCL-M pre and ORS pre scores) with the means
of symptomatology at terminus of treatment (PCL-M post and
ORS post scores) to assess treatment efficacy. Pearson’s correlation coefficients were used to test correlations between variables
(demographics, PCL-M, ORS, PAI, and CALPAS-G). Multiple linear regression analyses were used to test the impact of predictor
variables on treatment outcome (reduction in symptom severity
on PCL-M, increase in interpersonal dimensions on ORS). Given
that this was an exploratory pilot study and the n < 100, we did
not run a large correlation matrix; rather, we ran bivariate analyses based on our theoretical considerations (identified in previous research cited in the introduction). The significance level for
this study was set at p < .05.
RESULTS
Participant Demographics

A total of 38 participants were included in this study (37 male, 1
female). One participant dropped out due to leaving treatment
for a family emergency and was omitted from analysis. Paramet-

Table 1. Mean, Standard Deviation, and Minimum
and Maximum Values of Demographics
Demographic Variable

M

(SD)

Min

Max

Age

31

(6.81)

21

43

Number of Deployments

2.13

(1.34)

1

7

Number of Months Deployed

19.53

(10.02)

4

44

Number of Previous Marriages

.55

(.72)

0

2

Number of Children

1.39

(1.33)

0

5

ric participant demographics are detailed in Table 1. The majority of participants were married (55.3%), followed by divorced
(28.9%), single (7.9%), and separated (7.9%). Participants were
employed by three branches of the U.S. Military: Army (92.1%),
Air Force (5.3%), and Marine Corps (2.6%), and they consisted of
enlisted (92.1%), officer (5.2%), and chief warrant officer (2.6%)
ranks. Among participants, 13.2% were African American, 63.2%
were Caucasian, 10.5% were Latino(a), 2.6% were Native American/Alaska Native, 2.6% of Arabic origin, and 7.9% were Pacific
Islanders. All participants had a diagnosis of PTSD. A total of
68.4% had an additional alcohol-related diagnosis, and 24.3% of
participants (including those with alcohol-related diagnoses) also
had an additional diagnosis of chemical dependency.
Descriptive Statistics

Demographic variables did not correlate significantly with treatment outcome as measured by the PCL post and ORS post scores
in this study. Descriptive statistics for self-report measures are
detailed in Table 2. In this study, the overall alpha for internal
consistency on the PCL-M for the baseline score (α = 0.91) and
final score (α = 0.96) were excellent (α > 0.90; Kline, 1999). The
overall alpha for internal consistency on the ORS in this study
ranged from good (α > 0.80; Kline, 1999) to excellent for the
baseline score (α = 0.89) and final score (α = 0.96). The overall alpha for internal consistency on the CALPAS was good (α = 0.83).
Consistent with previous research, these results show very strong
reliability on all pre and post measures used in this study.

Table 2. Mean, Standard Deviation, and Minimum
and Maximum Values for Study Variables
Scale
Pre and Post Symptomatology
PCL Pre
PCL Post
ORS Pre
ORS Post
Baseline Symptomatology
DRRI A Scale (Pre Deployment Life Events)
DRRI I Scale (Combat Experiences)
DRRI J Scale (Post Battle Experiences)
DRRI L Scale (Post Deployment Support)
DRRI M Scale (Post Deployment Life Events)
Personality Factors
PAI ICN (Validity Scale – Inconsistency)
PAI INF (Validity Scale – Infrequency)
PAI NIM (Negative Impression Management)
PAI PIM (Positive Impression Management)
PAI SCZ S (Social Detachment)
PAI AGG A (Aggressive Attitude)
PAI AGG V (Verbal Aggression)
PAI AGG P (Physical Aggression)
PAI Total AGG (Aggression)
PAI ANT A (Antisocial Behaviors)
PAI ANT E (Egocentricity)
PAI ANT S (Stimulus Seeking)
PAI Total ANT (Antisocial)
PAI ALC (Alcohol Problems)
PAI DRG (Drug Problems)
PAI RXR (Treatment Rejection)
Group Cohesion
CALPAS PC (Patient Commitment)
CALPAS PWC (Patient Working Capacity)
CALPAS WSC (Working Strategy Consensus)
CALPAS MU (Member Understanding)

M

(SD)

Min

Max

60.71
49.39
13.56
24.98

(13.703)
(18.72)
(8.66)
(9.59)

2.40
1.92
3.05
5.68

4.21
3.61
3.68
6.68

5.05
11.16
11.79
51.45
4.86

(4.12)
(3.55)
(3.64)
(10.38)
(3.42)

0
2
0
21
0

14
15
15
70
1

56.17
54.39
73.47
41.21
67.89
63.83
62.00
73.42
68.89
64.47
57.08
68.44
66.71
68.13
64.18
36.08

(12.59)
(10.86)
(20.36)
(9.53)
(14.69)
(16.38)
(13.03)
(18.32)
(17.27)
(13.60)
(12.10)
(17.30)
(14.99)
(21.21)
(20.04)
(7.27)

34
40
44
25
43
34
34
42
37
41
39
40
40
41
42
25

82
79
122
57
97
84
82
103
95
93
82
103
98
104
112
55

14.16
12.54
14.35

(4.38)
(4.45)
(3.22)

0
4
5

18
18
18

14.43

(2.89)

7

18

Note. All PAI scores are reported as t values. PTSD Checklist – Military Version (PCL-M), Outcome
Rating Scale (ORS), Deployment Risk and Resilience Inventory (DRRI), Personality Assessment
Inventory (PAI), California Psychotherapy Alliance Scale – Group Version (CALPAS-G).

Treatment Outcome

A paired samples t-test showed a significant change between baseline symptomatology at onset of treatment and symptom severity
at terminus of treatment. The average PCL-M pre-treatment score

Table 3. Results of Pearson’s Correlation Analyses
Predictor Variable

PCL-M Post
Correlation

ORS Post
Correlation

Baseline Symptomatology
PCL-M Pre Score

.60**

-.26

ORS Pre Score

-.42**

.56**

DRRI Pre Deployment Life Events (A)

-.08

-.03

DRRI Combat Experiences (I)

.21

-.20

DRRI Post Battle Experiences (J)

.22

-.08

DRRI Post Deployment Support (L)

-.24

.36**

DRRI Post Deployment Life Events (M)

.19

-.20

.43**

-.39*

Personality Factors (PAI)
Neg Impression Mgmt (NIM)
Pos Impression Mgmt (PIM)

-.13

.13

Social Detachment (SCZ-S)

.56**

-.46**

Antisocial (ANT)

.05

-.14

Aggressive Attitude (AGG-A)

.38*

-.25

Group Cohesion (CALPAS-G)
Patient Commitment (PC)

-.15

.22

Patient Working Capacity (PWC)

-.58**

.41*

Working Strategy Consensus (WSC)

-.064

.27

Member Understanding (MU)

-.09

.37*

Note. *Significant at the 0.05 level (2-tailed); **significant at the 0.01 level (2-tailed). PTSD Checklist
– Military Version (PCL-M), Outcome Rating Scale (ORS), Deployment Risk and Resilience Inventory
(DRRI), Personality Assessment Inventory (PAI), California Psychotherapy Alliance Scale – Group
Version (CALPAS-G).

(at baseline) was 60.71 (SD = 13.70). The average PCL-M post
score was 49.39 (SD = 18.72). A comparison of means between
PCL scores showed a significant reduction in reported symptom
severity according to the criteria for PTSD diagnosis (paired t(37)
= 4.6, p < .001). Effect size was medium-large (d = .601). The average ORS pre score (at baseline) was 13.56 (SD = 8.66). The average ORS post score was 24.98 (SD = 9.59). In addition to exceeding the reliability change index of 5 points, the mean comparison
between ORS scores also resulted in a statistically significant improvement in global functioning across interpersonal domains
(paired t(37) = -8.185, p < .001). Effect size was medium (d = .560).

Correlation and Regression Statistics

Consistent with previous research, several predictor variables
correlated with treatment outcomes. Effect sizes ranged from
moderate (r > .30) to large (r > .50). These results are detailed
in Table 3. Analyses did not reveal any measures of association
between demographic and outcome variables. The strongest correlations were found between baseline symptomatology as measured by the PCL-M pre score and PCL-M post score (r(36) = .601,
p < .001), global functioning, as measured by the ORS pre and
ORS post (r(36) = .560, p < .001), the personality factor of social
detachment (PAI SCZ-S) and PCL-M post score (r(34) = .560, p <
.000), and the group cohesion measure of PWC and PCL-M post
score (r(36) = -.580, p < .001).
Linear regression analyses to predict the PCL-M post score (at
discharge) were performed in forward stepwise analysis. When
both predictors were entered into the equation, a significant regression equation was found (F(2,34) = 19.372, p < .000) with an
R2 of .533, with predictors accounting for 53.9% of the variance
in PCL-M post scores (PCL-Pre (R2 = .337) and PWC (R2 = .202).
Coefficients for the predictor variables included PCL-M pre score
(β =.46, t = 3.77, p < .001) and PWC (β =-.454, t = -3.72, p < .001).
Linear regression analyses to predict the ORS post score (at
discharge) were performed in forward stepwise analysis. When
both predictors were entered into the equation, results were consistent with previous regression analysis and resulted in a significant regression equation showing that ORS pre score (F(1,33) β =
12.51, p = .001) and PWC (F(2,32) = 9.24, p = .001) predicted ORS
post score, but that the other variables detailed in Table 3 did
not. Predictors accounted for 36.6% of the variance (R2 = .366;
ORS-Pre R2 = .275; PWC R2 = .091).
Additional Analyses

The significant results showing the ability of the PWC subscale
of the CALPAS-G to predict treatment outcome, in addition to
baseline symptomatology, led to additional analysis to determine
the strength of the association of these subscale items. The three
items of the PWC scale all correlated significantly with treatment

Table 4. Results of Pearson’s Correlation Analyses for PWC Items
CALPAS PWC Item

PCL-M Post Correlation

Question 2 (keeping thoughts to yourself)

.60*

Question 4 (Holding back feelings)

.38**

Question 11 (Unable to deepen understanding)

.40**

Note. *Significant at the 0.05 level (2-tailed); **significant at the 0.01 level (2-tailed).

outcome as measured by the PCL post score. These items were:
(2) “When important things come to mind, how often did you
find yourself keeping them to yourself rather than sharing them
with the group”; (4) “How much did you hold back your feelings
during the group therapy process”; and (11) “Did you have the
impression that you were unable to deepen your understanding
of what was bothering you?” Results of additional Pearson’s correlational analyses are detailed in Table 4.
DISCUSSION

The results of this pilot study suggest that inpatient group treatment for active duty military personnel significantly improved
patients’ perceptions of their overall functioning and significantly reduced their experience of symptoms associated with PTSD.
When PCL-M post score was used as a treatment outcome measuring reduction in PTSD-specific symptoms, PCL-Pre and PWC
accounted for 53.9% of the variance in outcome and demonstrating moderate effect size. Baseline symptomatology, as measured
by the PCL-M, baseline global functioning, as measured by the
ORS, and the PWC subscale of the group cohesion measure were
found to be significant predictors of positive treatment outcomes
(reduction in symptom severity and improvement in global functioning). These clinically significant results support two of the
principal hypotheses of this study: that (1) treatment of PTSD
using CPT in a group inpatient treatment setting is effective, and
(2) baseline symptomatology (including global functioning) and
group cohesion could significantly predict treatment outcome for
military personnel receiving treatment for combat-related PTSD
in a group, inpatient setting. The relationship between symptom
severity and treatment outcome is meaningful because it extends
the previous research regarding the predictive utility of symp-

tom severity to the treatment venue of a group setting (Karatzias
et al., 2007). The relationship between PWC and treatment outcome suggests that, consistent with Crowe and Grenyer’s (2008)
research, the patient’s willingness to engage in the group process
due to the nature of the group itself and to share and process personal information in a group setting are the functional aspects of
treatment of combat-related PTSD in a group setting.
Given that group modalities are the wave of the future for the
treatment of PTSD in combat veterans (Kingsley, 2007), it is important to know that a variable not relevant to individual treatment modalities—the capacity to work with others in the context
of a group—is a significant and unique predictor of treatment
outcome. This study suggests that group treatment for PTSD is
effective and may control for other factors that have been shown
to affect outcomes in individual treatment. This effect may be
moderated by the patient’s willingness to engage in the group
process and share personal information in the setting; that is, the
suggested effectiveness of group treatment appears to be significantly related to a patient’s willingness to engage in the particular
group treatment context. Group modalities of treatment should
foster healthy settings in which patients can engage in group
sharing and group process. Patients should be assessed for their
working capacity at the onset of treatment, and hesitations they
have about sharing in group should be addressed to encourage
this aspect of group cohesion.
These findings need to be considered in light of limitations
associated with this study. The sample for this study was small,
with limited statistical power. Given the nature of the treatment
setting, it is difficult to separate the effects of the various aspects
of multidisciplinary treatment (e.g., milieu, 12-step, psychopharmacological interventions) that participants received in addition
to their regular CPT groups. The study is from one inpatient
treatment setting that utilized CPT, and results may not be generalized to other treatment facilities. Results are from a predominantly male population, and a control group was not utilized.
Despite the aforementioned limitations, results from this study
support the theory that patient willingness to engage in treatment and be vulnerable in group settings and the facilitation of
this working capacity offered by the group are essential aspects

of the group treatment of PTSD. Findings suggest that focusing
solely on individual aspects of participants, such as personality
and demographics, is insufficient for group treatment of PTSD.
Also, when baseline symptomatology is combined with a factor
of group cohesion, more than 50% of the variance of treatment
outcome is accounted for, suggesting that group treatment is an
effective method for the treatment of PTSD.
Where this research supports an aspect of group cohesion as
a treatment outcome predictor, it does not identify factors that
enhance or inhibit the patient working capacity factor of group
cohesion. Future research may benefit from assessing aspects of
group treatment that increase the patient working capacity factor of group cohesion, therefore enhancing treatment efficacy. It
would be beneficial to have patients identify their perceived barriers to “self disclose and self-reflect on salient therapy themes”
(Gaston & Marmar, 1993, p. 5) in group treatment settings. Once
factors that enhance and inhibit this particular outcome predictor
are established, treatment programs may develop protocols and
progressive group ethos to address these factors. Future research
should also include the assessment of multiple populations, including more female participants, increased ethnic diversity, and
in multiple group settings, such as outpatient and day treatment
programs.
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